13-Hydroxy- and 13-oxooctadecadienoic acids: Novel substrates for human UDP-glucuronosyltransferases

被引:0
|
作者
Jude, AR
Little, JM
Bull, AW
Podgorski, I
Radominska-Pandya, A
机构
[1] Univ Arkansas, Dept Chem, Little Rock, AR 72204 USA
[2] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[3] Oakland Univ, Dept Chem, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although there are numerous studies of glucuronidation of endogenous compounds, information on the glucuronidation of fatty acids is lacking. In the present studies, both linoleic acid (LA) and its biologically active oxidized derivatives, 13-hydroxyoctadecadienoic acid (13-HODE) and 13-oxooctadecadienoic acid (13-OXO), have been shown to be effective substrates for human liver UDP-glucuronosyltransferases (UGT) and recombinant UGT2B7. LA (carboxyl glucuronide) and 13-OXO (carboxyl glucuronide, unproven) were actively glucuronidated by human liver microsomes (HLM) and human recombinant UGT2B7 with similar activities, in the range of 2 nmol/mg . min. The hydroxyl derivative of LA, 13-HODE, was glucuronidated at both the hydroxyl and carboxyl functions with carboxyl glucuronidation predominating (ratio of COOH/OH, 2:1). For all substrates, the K-m for formation of the carboxyl-linked glucuronide was in the range of 100 to 200 muM while that for the hydroxyl-linked glucuronide was somewhat lower (> 100 muM). This is the first demonstration of glucuronidation of LA and its oxidized derivatives, 13-HODE and 13-OXO, by HLM and recombinant UGT2B7.
引用
收藏
页码:652 / 655
页数:4
相关论文
共 34 条
  • [21] Glucuronidation of arachidonic acid, 20-hydroxy-eicosatetraenoic acid and prostaglandin E2 by human hepatic and intestinal UDP-glucuronosyltransferases and recombinant UGT2B7
    Sonka, J
    Little, J
    Samokyszyn, V
    Radominska-Pandya, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 194 - 194
  • [22] Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities
    Ohtsuki, Sumio
    Schaefer, Olaf
    Kawakami, Hirotaka
    Inoue, Tae
    Liehner, Stephanie
    Saito, Asami
    Ishiguro, Naoki
    Kishimoto, Wataru
    Ludwig-Schwellinger, Eva
    Ebner, Thomas
    Terasaki, Tetsuya
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (01) : 83 - 92
  • [23] N-Glucuronidation of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) and N-hydroxy-PhIP by specific human UDP-glucuronosyltransferases
    Malfatti, MA
    Felton, JS
    CARCINOGENESIS, 2001, 22 (07) : 1087 - 1093
  • [24] Biosynthesis of the Novel Endogenous 15-Lipoxygenase Metabolites N-13-Hydroxy-octodecadienoyl-ethanolamine and 13-Hydroxy-octodecadienoyl-glycerol by Human Neutrophils and Eosinophils
    Archambault, Anne-Sophie
    Tinto, Francesco
    Dumais, Elizabeth
    Rakotoarivelo, Volatiana
    Kostrzewa, Magdalena
    Plante, Pier-Luc
    Martin, Cyril
    Simard, Melissa
    Silvestri, Cristoforo
    Pouliot, Roxane
    Laviolette, Michel
    Boulet, Louis-Philippe
    Vitale, Rosa Maria
    Ligresti, Alessia
    Di Marzo, Vincenzo
    Flamand, Nicolas
    CELLS, 2021, 10 (09)
  • [25] 3-hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase
    Noe, MC
    Snow, SL
    Wolf-Gouveia, LA
    Mitchell, PG
    Lopresti-Morrow, L
    Reeves, LM
    Yocum, SA
    Liras, JL
    Vaughn, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (18) : 4727 - 4730
  • [26] Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): Role of UGT1A1,1A3 and 1A8
    Syed Muzeeb
    Shaik Jafar Sadik Basha
    Dhanya Shashikumar
    Ramesh Mullangi
    Nuggehally R. Srinivas
    European Journal of Drug Metabolism and Pharmacokinetics, 2006, 31 : 299 - 309
  • [27] Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): Role of UGT1A1, 1A3 and 1A8
    Muzeeb, Syed
    Basha, Shaik Jafar Sadik
    Shashikumar, Dhanya
    Mullangi, Ramesh
    Srinivas, Nuggehally R.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2006, 31 (04) : 299 - 309
  • [28] Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
    Tsoutsikos, P
    Miners, JO
    Stapleton, A
    Thomas, A
    Sallustio, BC
    Knights, KM
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (01) : 191 - 199
  • [29] The glucuronidation of Δ4-3-keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs):: 6α- and 21-hydroxyprogesterone are selective substrates for UGT2B7
    Bowalgaha, K.
    Elliot, D. J.
    Mackenzie, P. I.
    Knights, K. M.
    Miners, J. O.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) : 363 - 370
  • [30] SYNTHESIS OF 2 HYDROXY FATTY-ACIDS FROM 7,10,13,16,19-DOCOSAPENTAENOIC ACID BY HUMAN-PLATELETS
    CAREAGA, MM
    SPRECHER, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (23) : 4413 - 4417